(Q45722771)

15 December 2017

Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11. (English)

1 reference

15 December 2017

4

Joakim Dillner

1 reference

15 December 2017

Xiaohong Wang

1

1 reference

15 December 2017

Zhaohui Wang

series ordinal

2

1 reference

15 December 2017

Neil D Christensen

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

15 December 2017

1 reference

15 December 2017

311

1 reference

15 December 2017

1

1 reference

15 December 2017

213-221

1 reference

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Divergent human papillomavirus type 16 variants are serologically cross-reactive.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Immunological analyses of human papillomavirus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

HPV6b virus like particles are potent immunogens without adjuvant in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900179-X

7 January 2021

10.1016/S0042-6822(03)00179-X

Identifiers

DOI

1 reference

15 December 2017

1 reference